Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,455 public trials 324 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

NCT00103454

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Mission Viejo, California, United States

GSK Investigational Site Orange, California, United States

View all 49 locations

View Trial Details

Completed

Monitoring Adherence Using Mobile Technology

NCT02617420

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.

NCT00370591

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Manchester, Lancashire, United Kingdom

View Trial Details

Completed

Seasonal Allergic Rhinitis In Pediatric Subjects

NCT00107757

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations: GSK Investigational Site Scottsdale, Arizona, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Costa Mesa, California, United States

GSK Investigational Site Cudahy, California, United States

View all 65 locations

View Trial Details

Completed

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

NCT00109486

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +11 more
Locations: GSK Investigational Site Randers, Denmark

View Trial Details

Completed

A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.

NCT01499446

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil

GSK Investigational Site Pleven, Bulgaria

GSK Investigational Site Sofia, Bulgaria

GSK Investigational Site Sofia, Bulgaria

View all 64 locations

View Trial Details

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

NCT00169546

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Wellington, New Zealand

GSK Investigational Site Manchester, Lancashire, United Kingdom

View Trial Details

Completed

Investigation Of A New Medication (GW642444) In Asthmatic Patients

NCT00354874

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Wiesbaden, Hesse, Germany

GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany

GSK Investigational Site Gothenburg, Sweden

View Trial Details

Completed

Aerosol Deposition in Asthmatic Obese Women Using Heliox

NCT02620956

Conditions: Asthma, Body Weight, Bronchial Diseases, +15 more
Locations: Hospital the Federal University of Pernambuco Recife, Pernambuco, Brazil

View Trial Details

Completed

Advair Pediatric Once-Daily

NCT00920959

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Ozark, Alabama, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Little Rock, Arkansas, United States

View all 149 locations

View Trial Details